Table 5.
Study | Overall percentage decrease of fibroadenoma | |||||
---|---|---|---|---|---|---|
6 months, % | p value | 12 months, % | p value | 24 months, % | p value | |
Kovatcheva et al. (2015) [27] | 59.20 | <0.001 | 72.50 | <0.001 | N/A | N/A |
Peek et al. (2016) [28] | 43.50 | N/A | N/A | N/A | N/A | N/A |
Kovatcheva et al. (2017) [29] | 58.04 | N/A | 71.02 | 0.02 | 77.32 | 0.025 |
Kovatcheva et al. (2017) [2 HIFU] [29] | 50.44 | N/A | 86.28 | 0.02 | 90.47 | 0.025 |
Peek et al. (2017) [30] | 35 | <0.005 | 43.20 | <0.005 | N/A | N/A |
Hahn et al. (2018) [31] | 61.60 | N/A | 84.80 | N/A | N/A | N/A |
Imankulov et al. (2018) [32] | N/A | N/A | N/A | N/A | N/A | N/A |
Kwong et al. (2021) [33] | N/A | N/A | N/A | 0.046 | N/A | N/A |